These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12297129)

  • 21. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
    Teng CM; Hsueh CM; Chang YL; Ko FN; Lee SS; Liu KC
    J Pharm Pharmacol; 1997 Jul; 49(7):706-11. PubMed ID: 9255715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitory effect of various traditional Chinese medicines on rabbit platelet phospholipase A2 in vitro and suppressive effect of tôki-syakuyaku-san on increased aggregability in hypercholesterolemic rabbit ex vivo].
    Sato T; Yamaguchi H; Fujii T; Akiba S; Tamura A; Fujii T; Tatsumi Y; Miura O
    Yakugaku Zasshi; 1989 Nov; 109(11):869-76. PubMed ID: 2614670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicological effects of beryllium on platelets and vascular endothelium.
    Togna G; Togna AR; Russo P; Caprino L
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):262-7. PubMed ID: 9194409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment.
    Togna G; Tempesta E; Togna AR; Dolci N; Cebo B; Caprino L
    Haemostasis; 1985; 15(2):100-7. PubMed ID: 3924789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI; Crawford DD; Gimbrone MA
    J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
    Lagarde M; Bordet JC; Croset M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cobra venom phospholipase A2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophophatidylcholine.
    Teng CM; Kuo YP; Lee LG; Ouyang C
    Thromb Res; 1986 Dec; 44(6):875-86. PubMed ID: 3099424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis.
    Badimon L; Vilahur G; Rocca B; Patrono C
    Cardiovasc Res; 2021 Jul; 117(9):2001-2015. PubMed ID: 33484117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of prostacyclin/thromboxane formation by molsidomine during platelet-endothelial cell interactions.
    Bordet JC; Lagarde M
    Biochem Pharmacol; 1988 Oct; 37(20):3911-4. PubMed ID: 3142481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels.
    Stampfer MJ; Jakubowski JA; Faigel D; Vaillancourt R; Deykin D
    Am J Clin Nutr; 1988 Apr; 47(4):700-6. PubMed ID: 3128100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
    Mihara S; Fujimoto M; Okabayashi T
    Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet effects of chelerythrine chloride isolated from Zanthoxylum simulans.
    Ko FN; Chen IS; Wu SJ; Lee LG; Haung TF; Teng CM
    Biochim Biophys Acta; 1990 May; 1052(3):360-5. PubMed ID: 2162213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood.
    González-Correa JA; Arrebola MM; Guerrero A; Muñoz-Marín J; Ruiz-Villafranca D; Sánchez de La Cuesta F; De La Cruz JP
    Platelets; 2005; 16(3-4):171-9. PubMed ID: 16011961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.